Posted by Michael Wonder on 27 Jan 2016
FDA fails to monitor fast tracked drugs after approval, says US watchdog
20 January 2016 - The US FDA is not properly keeping track of medicines that have reached the market after going through one of the agency’s rapid approval programs, says a report by the Government Accountability Office, the auditing service of the US Congress.
For more details, go to: http://www.bmj.com/content/352/bmj.i371?etoc=
